QYLD vs XLV
Global X Nasdaq 100 Covered Call ETF vs Health Care Select Sector SPDR Fund
- • XLV has the lower expense ratio at 0.08% vs 0.60% for QYLD.
- • QYLD pays a higher dividend yield (5.94%).
Side-by-side metrics
| Metric | QYLD | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.60% | 0.08% |
Dividend yield Trailing 12-month yield. | 5.94% | 1.60% |
AUM Assets under management — bigger funds are typically more liquid. | $8.37B | $40.60B |
YTD return | 8.99% | 5.74% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.49 | 0.51 |
P/E ratio | 32.60 | 29.12 |
Last price | $18.40 | $161.81 |
Inception | — | — |
Issuer | Global X | State Street |
QYLD top holdings
| NVDA | NVIDIA Corp | 7.75% |
| AAPL | Apple Inc | 6.80% |
| MU | Micron Technology Inc | 5.75% |
| MSFT | Microsoft Corp | 4.43% |
| AMD | Advanced Micro Devices Inc | 4.18% |
| AMZN | Amazon.com Inc | 4.10% |
| TSLA | Tesla Inc | 3.36% |
| GOOGL | Alphabet Inc Class A | 3.33% |
| INTC | Intel Corp | 3.10% |
| GOOG | Alphabet Inc Class C | 3.08% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.48% |
| JNJ | Johnson & Johnson | 10.62% |
| ABBV | AbbVie Inc | 7.72% |
| UNH | UnitedHealth Group Inc | 6.56% |
| MRK | Merck & Co Inc | 5.51% |
| AMGN | Amgen Inc | 3.40% |
| TMO | Thermo Fisher Scientific Inc | 3.24% |
| ABT | Abbott Laboratories | 2.75% |
| GILD | Gilead Sciences Inc | 2.73% |
| ISRG | Intuitive Surgical Inc | 2.45% |
About QYLD
QYLD (Global X Nasdaq 100 Covered Call ETF) is Nasdaq-100 covered call income strategy. Managed by Global X, the fund carries $8.4B in assets under management, an expense ratio of 0.60%, a dividend yield of 5.94%. Its largest holding is NVIDIA Corp (NVDA), which represents 7.8% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 10.7%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $40.6B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.60%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.5% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.